The Effect of Bicarbonate Profiling in Dialysis Fluid on Phosphate Removal During Hemodialysis and Blood pH
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- The blood phosphorus concentration change in hemodialysis patient
研究概览
简要总结
Hyperphosphatemia is still an unresolved problem among hemodialysis patients and significantly increases the risk of death from cardiovascular diseases. Research to date has not answered the question of whether dialysate bicarbonate concentration profiling can improve phosphate removal and its concentration without negative impact on the acid-base balance. This study addressed this issue.
Twenty stable hemodialysis patients will enroll to a four-week study during which different dialysate bicarbonate concentration profiles will be used each week. Each patient will undergo the following profiles (one-week periods): Treatment A - stable dialysate bicarbonate concentration Dbic 35 mmol/L during the whole HD session, Treatment B - Dbic 35 mmol/L for the first two hours and Dbic 30 mmol/L for the next two hours and Treatment C - the opposite mid-HD change Dbic from 30 to 35 mmol/L and one week wash-out period between Treatment B and C. We will collect blood samples each hour during the session and one hour after HD completion.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •stable general condition
- •hemodialysis more than 3 months
- •Dialysis 3 times a week/ 4 hours +/- 20 minutes
- •Dialysis with arterio-venous fistulas
- •bicarbonate titer before hemodialysis 22-24 mmol/l
排除标准
- •diabetes mellitus
- •inflamation processes
- •usage of sevelamer last month
- •utrafiltration during dialysis more than 2500 ml
结局指标
主要结局
The blood phosphorus concentration change in hemodialysis patient
时间窗: 4 weeks
The blood phosphorus concentration change in hemodialysis patient using dialysate bicarbonate profiling
次要结局
- The maintaining the acid-base balance in accordance with applicable recommendations.(4 weeks)
研究者
Monika Wieliczko
Clinical Doctor
Medical University of Warsaw
